Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2017 | Overcoming the limits to widespread NGS implementation

Ola Landgren • 9 Dec 2017
ASH 2017
General

Next-generation sequencing (NGS) has been widely used in research for the past decade or more; however, its translation into the clinic has taken more time. Here, Ola Landgren, MD, PhD, from the Memorial Sloan Kettering Cancer Center, New York, NY, discusses the limits to widespread NGS implementation and how we can overcome them. This video was recorded at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA.

More from Ola Landgren

Implementing bispecific antibodies in triple-class-exposed multiple myeloma
1:46
Implementing bispecific antibodies in triple-class-exposed multiple myeloma
Ola Landgren • 25 Sep 2026
Expanding our understanding of the role of the tumor microenvironment in multiple myeloma
13:35
Expanding our understanding of the role of the tumor microenvironment in multiple myeloma
Gareth Morgan et al. • 11 Apr 2026
Register for the 13th Miami Myeloma MRD Meeting: insights from Ola Landgren
1:15
Register for the 13th Miami Myeloma MRD Meeting: insights from Ola Landgren
Ola Landgren • 24 Feb 2026
Where the MRD community meets: collaboration and innovation at the 13th Miami Myeloma MRD Meeting
1:42
Where the MRD community meets: collaboration and innovation at the 13th Miami Myeloma MRD Meeting
Ola Landgren • 24 Feb 2026

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals